Cellular Dynamics signs supply agreement with NIHS, terms not disclosed Cellular Dynamics (ICEL) announced signing a long-term supply agreement with the Nestle (NSRGY) Institute of Health Sciences SA, or NIHS. Terms of the agreement were not disclosed. Bob Palay, Cellular Dynamics CEO, said, "The ongoing work and this long-term supply agreement with NIHS demonstrate the utility and broad applicability of our iCell and MyCell Products. Our customers already benefit from a reliable supply of human iPSCs and human differentiated cells for their biomedical research and drug discovery. This supply agreement with NIHS adds nutritional research as yet another field that will benefit from CDI's products and expertise."